Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
August 1, 1996
Modulation of cisplatin antitumor activity by short infusional high-dose cytosine arabinoside in advanced pretreated head and neck carcinoma: a phase II study
S Jelic, L Mitrovic, V Kovcin, et al.
Cancer Research
|
May 1, 1992
Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice
T W Redding, A V Schally, S Radulovic, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 10, 2005
The evaluation of cytotoxic activity of planar pentadentate ligand 2',2"'-(2,6-pyridindiyldiethylidyne) dioxamohydrazide dihydrate (H2l x 2H2O) and its metal coordination complexes; pitfalls in the use of the MTT-assay
M J Lazic, K K Andelkovic, D M Sladic, et al.
Cancer
|
February 15, 1994
Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice
T Yano, J Pinski, K Szepeshazi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
August 4, 2009
Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo
S S Arandjelovic, K S Bjelogrlic, N N Malesevic, et al.
The International Journal of Biological Markers
|
February 17, 2017
Analysis of T-cell clonality pattern in tumor samples of breast cancer patients
B M Cikota, M V Brankovic-Magic, V S Jovic, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1992
Biological activity and receptor binding characteristics to various human tumors of acetylated somatostatin analogs
J Pinski, S Milovanovic, T Yano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1996
Isolation of Rickettsia akari from a patient in a region where Mediterranean spotted fever is endemic
S Radulovic, H M Feng, M Morovic, et al.
Anti-Cancer Drugs
|
October 1, 1992
Selective uptake of the somatostatin analog RC-160 across the blood-brain tumor barrier of mice with KHT sarcomas
W A Banks, A J Kastin, S Radulovic, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 1, 1996
Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting
S M Bosnjak, Z B Neskovic-Konstantinovic, D J Jovanovic-Micic, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Journal of Chemotherapy (Florence, Italy)
|
August 1, 1996
Modulation of cisplatin antitumor activity by short infusional high-dose cytosine arabinoside in advanced pretreated head and neck carcinoma: a phase II study
S Jelic, L Mitrovic, V Kovcin, et al.
Cancer Research
|
May 1, 1992
Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice
T W Redding, A V Schally, S Radulovic, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 10, 2005
The evaluation of cytotoxic activity of planar pentadentate ligand 2',2"'-(2,6-pyridindiyldiethylidyne) dioxamohydrazide dihydrate (H2l x 2H2O) and its metal coordination complexes; pitfalls in the use of the MTT-assay
M J Lazic, K K Andelkovic, D M Sladic, et al.
Cancer
|
February 15, 1994
Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice
T Yano, J Pinski, K Szepeshazi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
August 4, 2009
Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo
S S Arandjelovic, K S Bjelogrlic, N N Malesevic, et al.
The International Journal of Biological Markers
|
February 17, 2017
Analysis of T-cell clonality pattern in tumor samples of breast cancer patients
B M Cikota, M V Brankovic-Magic, V S Jovic, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
May 1, 1992
Biological activity and receptor binding characteristics to various human tumors of acetylated somatostatin analogs
J Pinski, S Milovanovic, T Yano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1996
Isolation of Rickettsia akari from a patient in a region where Mediterranean spotted fever is endemic
S Radulovic, H M Feng, M Morovic, et al.
Anti-Cancer Drugs
|
October 1, 1992
Selective uptake of the somatostatin analog RC-160 across the blood-brain tumor barrier of mice with KHT sarcomas
W A Banks, A J Kastin, S Radulovic, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 1, 1996
Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting
S M Bosnjak, Z B Neskovic-Konstantinovic, D J Jovanovic-Micic, et al.
Page
of 8